SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Medical Technology Systems, Inc.
--------------------------------
(Name of Issuer)
Common Stock
------------
(Title of Class of Securities
58462R505
---------
(CUSIP Number)
Gerald Couture, 901 Chestnut Street, Suite A, Clearwater,FL 33756,(727)447-5511
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
January 19, 1999
----------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box___.
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
(Continued on following pages)
1
<PAGE>
CUSIP NO. 58462R505 Page 2 of 5
1 Names of Reporting Person
SS or IRS Identification Nos. of Above Person
Couture & Company, Inc.
Check the Appropriate Box if a Member of a Group*
2 (a) x
Gerald Couture (b)
3 SEC use only
Source of Funds*
4
SC.
5 Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e)___
Citizenship or Place of Organization
6
Florida
7 Sole Voting Power
NUMBER OF
SHARES
BENEFICIALLY 8 Shared Voting Power 287,318
OWNED BY
EACH 9 Sole Dispositive Power 287,318
REPORTING
PERSON WITH
10 Shared Dispositive Power
11 Aggregate Amount Beneficially Owned by Each
Reporting Person 633,837
12 Check if the Aggregate Amount in Row (11)
Excludes Certain Shares* ____
13 Percent of Class Represented by Amount in Row (11) 9.9%
14 Type of Reporting Person* CO
* SEE INSTRUCTIONS BEFORE FILLING OUT!
2
<PAGE>
CUSIP NO. 58462R505 Page 3 of 5
Names of Reporting Person
1 SS or IRS Identification Nos. of Above Person
Gerald Couture
Check the Appropriate Box if a Member of a Group*
2 (a)x
Couture & Company, Inc. (b)
3 SEC USE ONLY
Source of Funds*
4
SC.
5 Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) ____
Citizenship or Place of Organization
6
U.S.
7 Sole Voting Power 346,519
NUMBER OF
SHARES
BENEFICIALLY 8 Shared Voting Power
OWNED BY
EACH 9 Sole Dispositive Power 346,519
REPORTING
PERSON WITH
10 Shared Dispositive Power
11 Aggregate Amount Beneficially Owned by Each
Reporting Person 633,837
12 Check if the Aggregate Amount in Row (11)
Excludes Certain Shares* ___
13 Percent of Class Represented by Amount in Row (11) 9.9%
14 Type of Reporting Person* IN
SEE INSTRUCTIONS BEFORE FILLING OUT!
3
<PAGE>
Item 1. Security and Issuer.
--------------------
Common Stock
Medical Technology Systems, Inc.
12920 Automobile Blvd., Clearwater, FL 33762
Item 2. Identity and Background.
------------------------
Item 2. (a) Gerald Couture
Item 2. (b) 901 Chestnut Street, Suite A, Clearwater, FL 33756
Item 2. (c) Couture & Company, Inc.
Item 2. (d) No
Item 2. (e) No
Item 2. (f) USA
Item 3. Source and Amount of Funds or Other Consideration.
--------------------------------------------------
In consideration of amounts due pursuant to employment
severance agreement.
Item 4. Purpose of Transaction.
-----------------------
Investment
Item 5. Interest in Securities of the Issuer.
-------------------------------------
Item 5. (a) 633,837
Item 5. (b) 633,837
Item 5. (c) None
Item 5. (d) None
Item 5. (e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships
With Respect to Securities of the Issuer.
-----------------------------------------
None
Item 7. Material to be Filed as Exhibits.
---------------------------------
None
4
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: 3/9/99
---------
/s/ Gerald L. Couture
---------------------
Gerald L. Couture
Gerald Couture, President and as Individual
-------------------------------------------
Name
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of this filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001).
5
